Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25 mg group compared with a 2.2% reduction in the placebo group.

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Semaglutide may be prescribed for different reasons and some forms may be more suitable for you than others: Ozempic. Ozempic is approved by the FDA (U.S. Food and Drug Administration) for type 2 ...

Semaglutide is the active ingredient in the ... Ozempic is a weekly injection approved by the FDA (U.S. Food and Drug Administration) to treat type 2 diabetes. It’s sometimes prescribed off ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group. The Food and Drug Administration (FDA) has accepted for review ...